Lung cancer is a leading cause of cancer death worldwide, and non–small cell lung carcinoma (NSCLC) accounts for 80% of the cases. Even the most innovative therapeutic regimens do not increase overall 5-year survival rates for NSCLC to >15%. Early detection methods could lead to intervention
No takes yet. Share an insight, caveat, or question.
T.M. Penning (2005) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: